These resistant lines consistently exhibited elevated Mcl-1 expression relative to other anti-apoptotic proteins, supporting previous literature showing Mcl-1 upregulation may be a mediator of drug resistance in MM [79]. This evidence concerns the gene MCL1 and Miyoshi myopathy.